SCRI

Today's Clinical Trials. Tomorrow's Therapies. Oncology-Focused CRO Supports biopharma and biotechnology companies in the development and execution of oncology clinical trials. The CRO offers a broad range of services tailored to the unique requirements of oncology studies. Scientific Key Opinion Leaders Faculty of physicians who oversees optimal execution of all aspects of clinical research. Centralized SMO Provides comprehensive management and operational support for sites on phase I through III industry-sponsored and investigator-initiated trials. Personalized Medicine Informs targeted treatment and trial strategies for patients and biopharma partners based on real-world data powered by Genospace technology. Our partners benefit from Accelero, our Accelerated Operations Model, which maximizes all functions of SCRI to accelerate drug development and optimize clinical trial delivery. SCRI.com 1121/24SCM004/R7-CMYK Sarah Cannon Research Institute (SCRI) is one of the world's leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development and has contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI's research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. We help our partners accelerate drug development & enhance clinical trial delivery

• Cover